Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C18H35O2.Al.HO |
Molecular Weight | 610.9275 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O
InChI
InChIKey=RDIVANOKKPKCTO-UHFFFAOYSA-K
InChI=1S/2C18H36O2.Al.H2O/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;;/h2*2-17H2,1H3,(H,19,20);;1H2/q;;+3;/p-3
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C18H35O2 |
Molecular Weight | 283.4693 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Al |
Molecular Weight | 26.9815 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/inactive/aluminum-stearate-184.html | https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htmhttp://www.doiserbia.nb.rs/img/doi/1450-7188/2003/1450-71880334055L.pdfCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25063173 | https://www.ncbi.nlm.nih.gov/pubmed/967230 | https://www.ncbi.nlm.nih.gov/pubmed/1234981 | https://www.ncbi.nlm.nih.gov/pubmed/374763
Sources: https://www.drugs.com/inactive/aluminum-stearate-184.html | https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htmhttp://www.doiserbia.nb.rs/img/doi/1450-7188/2003/1450-71880334055L.pdf
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25063173 | https://www.ncbi.nlm.nih.gov/pubmed/967230 | https://www.ncbi.nlm.nih.gov/pubmed/1234981 | https://www.ncbi.nlm.nih.gov/pubmed/374763
Because of its unusually heavy bodying properties, aluminum monostearate is used in the manufacture of paints, inks, greases, and waxes In recent years, hydrophobic aluminum monostearate was tested as a low-solubility denitrification substrate for anaerobic bacteria and a source of aluminum for phosphate precipitation. Aluminum monostearate can be used as a component of vehicle for delivery of drugs.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | Monoket Approved UseMonoket® is indicated for the prevention and treatment of angina pectoris due to coronary artery
disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this
product to be useful in aborting an acute anginal episode. Launch Date1991 |
|||
PubMed
Title | Date | PubMed |
---|---|---|
Serum concentrations following five treatment schedules with procaine penicillin in oil with aluminum monostearate. | 1949 Feb |
|
Results of single and multiple injection schedules for the treatment of early syphilis with procaine penicillin in oil and aluminum monostearate. | 1950 |
|
"One shot" treatment of venereal diseases employing procaine penicillin G with aluminum monostearate (P. A. M.). | 1950 Mar |
|
Prolonged effect of riboflavin: aluminum monostearate suspensions in man. | 1957 Feb |
|
Long-acting narcotic antagonist complexes. | 1975 |
|
Penicillin levels in blood and CSF achieved by treatment of syphilis. | 1979 Jun 8 |
|
Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of eudragit RS microspheres. | 2006 Feb 24 |
|
Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres. | 2006 Mar |
|
Metal stearate distributions in modern artists' oil paints: surface and cross-sectional investigation of reference paint films using conventional and synchrotron infrared microspectroscopy. | 2012 Oct |
|
Hydrophobic chitosan sponges modified by aluminum monostearate and dehydrothermal treatment as sustained drug delivery system. | 2014 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://books.google.ru/books?id=JwQlBQAAQBAJ&pg=PA116&lpg=PA116&dq=ALUMINUM+STEARATE retrieved from Pharmaceutical and Cosmetic Products for Topical Administration: Pharmaceutical Monographs by Van Abbé, p. 116 https://books.google.ru/books?id=egPMBQAAQBAJ&pg=PA160&lpg=PA160&dq=ALUMINUM+STEARATE retrieved from Handbook of Pharmaceutical Manufacturing Formulations: Semisolid Products By Sarfaraz K. Niazi, p.160
topical use
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:23 GMT 2023
by
admin
on
Fri Dec 15 15:04:23 GMT 2023
|
Record UNII |
7P1HP1B9UI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 178.3297
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300-92-5
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
100000133528
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
206-101-8
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
DTXSID1027136
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
7P1HP1B9UI
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
5487
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
7P1HP1B9UI
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
9315
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
522176
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | |||
|
1307778
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB51604
Created by
admin on Fri Dec 15 15:04:23 GMT 2023 , Edited by admin on Fri Dec 15 15:04:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |